December 8, 2025

Rhythm Pharmaceuticals (RYTM) Stock Analysis: Exploring a 21% Upside Potential in the Biotech Sector

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) has captured investor interest, showcasing a significant potential upside of 21.41% according to analysts’ average target price projections. As a commercial-stage biopharmaceutical company, Rhythm Pharmaceuticals..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Navigating Growth Amidst Challenges

Teva Pharmaceutical Industries (NYSE: TEVA) stands as a formidable player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. Based in Israel, Teva commands a significant..

AptarGroup, Inc. (ATR) Investor Outlook: Unpacking a 32.42% Upside Potential

AptarGroup, Inc. (NYSE: ATR) stands out in the healthcare sector, specifically within the medical instruments and supplies industry, with a robust market capitalization of $8.03 billion. As an investor, understanding..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a 17% Upside Potential Amidst Biotech Innovations

Roivant Sciences Ltd. (NASDAQ: ROIV), a UK-based biotechnology innovator, has captured investor attention with its ambitious pipeline of therapeutic candidates and a compelling 17.05% potential upside as indicated by analyst..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Challenges with a $4.83 Billion Market Cap

Oscar Health, Inc. (NYSE: OSCR), a prominent player in the healthcare technology sector, is gaining attention from investors thanks to its innovative approach to health insurance and a sizable market..

Alkermes plc (ALKS) Stock Analysis: A Healthcare Contender with 48.63% Potential Upside

Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector focusing on specialty and generic drug manufacturing, offers a compelling opportunity for investors. With its headquarters in Dublin, Ireland,..

Hologic, Inc. (HOLX) Stock Analysis: Navigating Growth in Women’s Health with a 2% Upside Potential

Hologic, Inc. (NASDAQ: HOLX), a prominent player in the healthcare sector, has carved a niche in the medical instruments and supplies industry with a strong focus on women’s health. Headquartered..

RadNet, Inc. (RDNT) Stock Analysis: A 16.7% Potential Upside in the Healthcare Diagnostics Sector

For investors seeking opportunities in the healthcare sector, RadNet, Inc. (NASDAQ: RDNT) presents an intriguing case. With a market capitalization of $6.06 billion, RadNet has established itself as a prominent..

Moderna, Inc. (MRNA) Stock Analysis: Navigating a 29% Potential Upside Amidst Volatility

Moderna, Inc. (MRNA), a beacon in the biotechnology sector, continues to capture investor attention not only due to its groundbreaking work in mRNA medicines but also because of its current..

Centene Corporation (CNC) Stock Analysis: Navigating Revenue Growth and Market Volatility

Centene Corporation (NYSE: CNC), a prominent player in the healthcare plans industry, has garnered attention with its substantial revenue growth despite facing notable challenges in profitability. With a market capitalization..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a 27.85% Potential Upside in the Healthcare Sector

Lantheus Holdings, Inc. (NASDAQ: LNTH), a prominent player in the healthcare sector, stands out in the niche market of diagnostic and therapeutic products. With a market capitalization of $4.3 billion,..

Tempus AI, Inc. (TEM) Stock Analysis: Navigating a Healthcare Tech Giant with 19% Potential Upside

Tempus AI, Inc. (NASDAQ: TEM) is carving its path in the healthcare technology sector with a focus on innovative diagnostic and data solutions. Based in Chicago, Illinois, and formerly known..

Cytokinetics, Inc. (CYTK) Stock Analysis: Unveiling a 21% Upside Potential Amidst Revolutionary Biotech Advances

Cytokinetics, Incorporated (NASDAQ: CYTK) stands at the forefront of the biotechnology sector, pursuing innovative solutions to address debilitating diseases through muscle activators and inhibitors. With a market capitalization of $8.03..

The Ensign Group, Inc. (ENSG) Stock Analysis: A Healthcare Powerhouse with 16.42% Upside Potential

In the rapidly evolving healthcare sector, The Ensign Group, Inc. (NASDAQ: ENSG) stands out as a resilient player, delivering impressive growth and promising potential for investors. With a market capitalization..

Repligen Corporation (RGEN): Analyst Consensus Highlights 13.68% Upside Potential

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector specializing in medical instruments and supplies, is drawing significant attention from investors with its promising growth trajectory and robust..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: 28% Potential Upside Attracts Investors

Prestige Consumer Healthcare Inc. (NYSE: PBH) is making waves in the healthcare sector with a promising potential upside of 28.25%. This specialty and generic drug manufacturer, based in Tarrytown, New..

Inspire Medical Systems, Inc. (INSP): Investor Outlook Reveals Strong Buy Ratings in Medical Device Sector

Inspire Medical Systems, Inc. (NYSE: INSP) stands out in the healthcare sector, particularly within the medical devices industry, as a company committed to addressing the prevalent issue of obstructive sleep..

Neurocrine Biosciences, Inc. (NBIX): Investor Outlook with a Promising 13.12% Potential Upside

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is making waves in the healthcare sector with a compelling growth trajectory that has caught the attention of investors. As a specialty drug manufacturer, Neurocrine’s..

TransMedics Group, Inc. (TMDX) Investor Outlook: A Healthcare Pioneer with 32% Revenue Growth and Strong Analyst Support

TransMedics Group, Inc. (TMDX) is capturing the attention of individual investors with its innovative approach to organ transplant therapy. Operating within the healthcare sector, specifically the medical devices industry, TransMedics..

Stevanato Group S.p.A. (STVN) Investor Outlook: Analyzing Growth Potential with a 29.42% Upside

Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the healthcare sector, is catching the eye of investors with a potential upside of 29.42%. As a key provider of medical..

Search

Funds

December 8, 2025

Search

Funds

December 8, 2025

FTSE 100

Funds